Trusted Resources: Education
Scientific literature and patient education texts
Prenatal Diagnosis of Mucopolysaccharidoses Type II by Two-Dimensional Electrophoresis and Mass Spectrometry in Amniotic Fluid
source: The journal of obstetrics and gynaecology research
year: 2022
authors: Aboulnasr AA,Elnouri A,Abdel Sameea G,Gouda AS,Ibrahim MM,Shalabi TA,Gaber KR
summary/abstract:To introduce a quantitative determination of heparan sulfate and dermatan sulfate by mass spectrometry and to compare it with two-dimensional electrophoresis of the glycosaminoglycans in the amniotic fluid for the prenatal diagnosis of mucopolysaccharidoses type II (MPS II).
organization: Prenatal Diagnosis and Fetal Medicine Department, National Research Centre, Giza, Egypt.DOI: 10.1111/jog.15135
read more
BookmarkRelated Content
-
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysacc...AVROBIO, Inc., a leading clinical-stage ...
-
X-Linked Recessive Inheritance Pattern in MPS II (Hunter Syndrome)https://www.onempsvoice.com/wp-content/u...
-
Joseph Muenzer, MD, PhDJoseph Muenzer, MD, PhD is a Professor i...
-
Impact of the COVID-19 Pandemic on the Standard of Care for Patients With Lysosomal Storage Diseases: A Survey of He...The impact of the COVID-19 pandemic on t...
-
A Guide to Understanding MPS IMPS I is a mucopolysaccharide disease al...
-
Divergent Developmental Trajectories in Two Siblings With Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome...Mucopolysaccharidosis type II (MPS II; H...
-
Golgi Requires a New Casting in the Screenplay of Mucopolysaccharidosis II CytopathologyLysosome (L), a hydrolytic compartment o...
Powered by
